Cargando…

Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer

The mitochondrion is a very versatile organelle that participates in some important cancer-associated biological processes, including energy metabolism, oxidative stress, mitochondrial DNA (mtDNA) mutation, cell apoptosis, mitochondria-nuclear communication, dynamics, autophagy, calcium overload, im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Liang, Zhan, Xianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045977/ https://www.ncbi.nlm.nih.gov/pubmed/35498135 http://dx.doi.org/10.1155/2022/5634724

Ejemplares similares

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022)

Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics
por: Li, Na, et al.
Publicado: (2019)

Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas
por: Li, Na, et al.
Publicado: (2019)

The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
por: Lu, Miaolong, et al.
Publicado: (2019)

Quantitative analysis of the human ovarian carcinoma mitochondrial phosphoproteome
por: Li, Na, et al.
Publicado: (2019)

The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues
por: Zhan, Xianquan, et al.
Publicado: (2018)

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma
por: Colic, Eva, et al.
Publicado: (2022)

Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2021)

Altered L-Arginine Metabolic Pathways in Gastric Cancer: Potential Therapeutic Targets and Biomarkers
por: Bednarz-Misa, Iwona, et al.
Publicado: (2021)

Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
por: Musicco, Clara, et al.
Publicado: (2023)

Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
por: Li, Na, et al.
Publicado: (2019)

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
por: Tryphena, Kamatham Pushpa, et al.
Publicado: (2023)

Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers
por: Ye, Zhen, et al.
Publicado: (2021)

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
por: Li, Yuting, et al.
Publicado: (2023)

Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets
por: O’Day, Danton H.
Publicado: (2023)

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019)

Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas
por: Long, Ying, et al.
Publicado: (2019)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Mitochondrial Dysfunction as a Therapeutic Target in COPD
por: CHUNG, Kian Fan
Publicado: (2017)

Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy
por: Feng, Baoyi, et al.
Publicado: (2020)

Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
por: Brummelhuis, Iris S., et al.
Publicado: (2021)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis
por: Zheng, Peixian, et al.
Publicado: (2022)

Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
por: Li, Na, et al.
Publicado: (2020)

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
por: Sun, Tianshui, et al.
Publicado: (2020)

Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1
por: Baloch, Tahira, et al.
Publicado: (2019)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer
por: Tan, Elaine S., et al.
Publicado: (2022)

Potential biomarkers and targets of mitochondrial dynamics
por: Li, Liyang, et al.
Publicado: (2021)

Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer
por: Liu, Rui-ji, et al.
Publicado: (2021)

104 Parkin-independent Pathway of Mitophagy as a Potential Target Mitochondrial Dysfunctions in Burns
por: Chen, Jingyuan, et al.
Publicado: (2022)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
por: Izzo, Antonella, et al.
Publicado: (2018)

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
por: He, Ting, et al.
Publicado: (2023)

Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes
por: Li, Na, et al.
Publicado: (2022)

HSP60 Regulates Lipid Metabolism in Human Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9hif97fnfbseddm1hopfr0sa8